{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:45:40Z","timestamp":1760233540574,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proteomes"],"abstract":"<jats:p>The clinical course of chronic lymphocytic leukemia (CLL) is very ambiguous, showing either an indolent nature of the disease or having latent dangerous progression, which, if diagnosed, will require an urgent therapy. The prognosis of the course of the disease and the estimation of the time of therapy initiation are crucial for the selection of a successful treatment strategy. A reliable estimating index is needed to assign newly diagnosed CLL patients to the prognostic groups. In this work, we evaluated the comparative expressions of proteins in CLL blood cells using a label-free quantification by mass spectrometry and calculated the integrated proteomic indexes for a group of patients who received therapy after the blood sampling over different periods of time. Using a two-factor linear regression analysis based on these data, we propose a new pipeline for evaluating model development for estimation of the moment of therapy initiation for newly diagnosed CLL patients.<\/jats:p>","DOI":"10.3390\/proteomes9010003","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T12:28:31Z","timestamp":1611577711000},"page":"3","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomics-Based Regression Model for Assessing the Development of Chronic Lymphocytic Leukemia"],"prefix":"10.3390","volume":"9","author":[{"given":"Varvara I.","family":"Bakhtina","sequence":"first","affiliation":[{"name":"Department of Hematology, Krasnoyarsk Regional Clinical Hospital, 660022 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry V.","family":"Veprintsev","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Science\u201d, 660036 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana N.","family":"Zamay","sequence":"additional","affiliation":[{"name":"Laboratory for Biomolecular and Medical Technologies, Krasnoyarsk State Medical University Named after Prof. V.F. Voyno-Yasenetsky, 660022 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina V.","family":"Demko","sequence":"additional","affiliation":[{"name":"Department of Hematology, Krasnoyarsk Regional Clinical Hospital, 660022 Krasnoyarsk, Russia"},{"name":"Faculty of Medicine, Krasnoyarsk State Medical University Named after Prof. V.F. Voyno-Yasenetsky, 660022 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gleb G.","family":"Mironov","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N6N5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0514-599X","authenticated-orcid":false,"given":"Maxim V.","family":"Berezovski","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N6N5, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina M.","family":"Petrova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Krasnoyarsk State Medical University Named after Prof. V.F. Voyno-Yasenetsky, 660022 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna S.","family":"Kichkailo","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Science\u201d, 660036 Krasnoyarsk, Russia"},{"name":"Laboratory for Biomolecular and Medical Technologies, Krasnoyarsk State Medical University Named after Prof. V.F. Voyno-Yasenetsky, 660022 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2826-5751","authenticated-orcid":false,"given":"Yury E.","family":"Glazyrin","sequence":"additional","affiliation":[{"name":"Laboratory for Digital Controlled Drugs and Theranostics, Federal Research Center \u201cKrasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Science\u201d, 660036 Krasnoyarsk, Russia"},{"name":"Laboratory for Biomolecular and Medical Technologies, Krasnoyarsk State Medical University Named after Prof. V.F. Voyno-Yasenetsky, 660022 Krasnoyarsk, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/asheducation-2005.1.278","article-title":"CLL Biology and Prognosis","volume":"2005","author":"Dighiero","year":"2005","journal-title":"Hematology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic Lymphocytic Leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.2174\/138161212801227104","article-title":"Novel insights in molecular mechanisms of CLL","volume":"18","author":"Zanesi","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.blre.2008.03.003","article-title":"New prognostic markers in chronic lymphocytic leukemia","volume":"22","author":"Moreno","year":"2008","journal-title":"Blood Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2141.2011.08974.x","article-title":"Defining the prognosis of early stage chronic lymphocytic leukaemia patients","volume":"156","author":"Pepper","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jso.23192","article-title":"Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer","volume":"107","author":"Winter","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/asheducation-2010.1.77","article-title":"Prognostic markers and stratification of chronic lymphocytic leukemia","volume":"2010","author":"Furman","year":"2010","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program Book"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/pr5002803","article-title":"Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia","volume":"13","author":"Alsagaby","year":"2014","journal-title":"J. Proteome Res."},{"key":"ref_12","first-page":"1419","article-title":"Prediction of Heart Disease using Multiple Linear Regression Model","volume":"5","author":"Polaraju","year":"2017","journal-title":"Int. J. Eng. Dev. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_14","unstructured":"(2020, December 01). Cross-Validation: Evaluating Estimator Performance\u2014Scikit-Learn 0.21.2 Documentation. Available online: https:\/\/scikit-learn.org\/stable\/modules\/cross_validation.html#cross-validation."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3349\/ymj.2009.50.3.399","article-title":"Expression of Heat Shock Protein 60 kDa Is Upregulated in Cervical Cancer","volume":"50","author":"Hwang","year":"2009","journal-title":"Yonsei Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41419-017-0196-z","article-title":"Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1\/2 activation during pancreatic cancer cell growth","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2017.01.009","article-title":"IgG1-iS18 impedes the adhesive and invasive potential of early and late stage malignant melanoma cells","volume":"351","author":"Munien","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/cbf.3225","article-title":"The 37-kDa laminin receptor precursor regulates the malignancy of human glioma cells: The 37-kDa laminin receptor precursor regulated glioma cells","volume":"34","author":"Wu","year":"2016","journal-title":"Cell Biochem. Funct."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Khumalo, T., Ferreira, E., Jovanovic, K., Veale, R.B., and Weiss, S.F.T. (2015). Knockdown of LRP\/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139584"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s13277-015-3873-5","article-title":"Inhibition of human 67-kDa laminin receptor sensitizes multidrug resistance colon cancer cell line SW480 for apoptosis induction","volume":"37","author":"Lu","year":"2016","journal-title":"Tumour Biol. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/cmble-2015-0031","article-title":"The transition of the 37-kDa laminin receptor (RPSA) to higher molecular weight species: SUMOylation or artifact?","volume":"20","author":"Digiacomo","year":"2015","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/1535-7163.MCT-14-0142","article-title":"Significance of Polypyrimidine Tract\u2013Binding Protein 1 Expression in Colorectal Cancer","volume":"14","author":"Takahashi","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_23","first-page":"245","article-title":"Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM","volume":"7","author":"Jiang","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2016.11.002","article-title":"Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells","volume":"385","author":"Jo","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/brain\/awp153","article-title":"Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines","volume":"132","author":"Cheung","year":"2009","journal-title":"Brain J. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1038\/sj.onc.1210307","article-title":"Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro","volume":"26","author":"He","year":"2007","journal-title":"Oncogene"}],"container-title":["Proteomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-7382\/9\/1\/3\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:14:33Z","timestamp":1760159673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-7382\/9\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["proteomes9010003"],"URL":"https:\/\/doi.org\/10.3390\/proteomes9010003","relation":{},"ISSN":["2227-7382"],"issn-type":[{"type":"electronic","value":"2227-7382"}],"subject":[],"published":{"date-parts":[[2021,1,23]]}}}